Ginger Gregory - 29 Jan 2024 Form 4 Insider Report for BIOGEN INC. (BIIB)

Reporting relationship: EVP, Human Resources
Issuer ticker: BIIB
Reported as of: 29 Jan 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 31 Jan 2024, 17:30:27 UTC
Prior SEC filing: 02 May 2023
Next SEC filing: 09 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Wendell Taylor, attorney in fact for Ginger Gregory

Key filing fact

Ginger Gregory filed Form 4 for BIOGEN INC. (BIIB) on 31 Jan 2024.

Key facts

This page summarizes Ginger Gregory's Form 4 filing for BIOGEN INC. (BIIB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 31 Jan 2024, 17:30.

Change

Previous filing in this sequence was filed on 02 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIIB transaction Derivative

Performance Stock Unit

Award

Transaction value: $0
Shares: +3,197
Change %
Price: $0.000000
Shares after: 3,197
Date: 29 Jan 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,197
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 18, 2021. The PSUs will vest on February 18, 2024.